Mill Creek Capital Advisors, LLC Gilead Sciences, Inc. Transaction History
Mill Creek Capital Advisors, LLC
- $4.12 Billion
- Q4 2024
A detailed history of Mill Creek Capital Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mill Creek Capital Advisors, LLC holds 2,581 shares of GILD stock, worth $268,630. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,581
Previous 2,768
6.76%
Holding current value
$268,630
Previous $232,000
2.59%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding GILD
# of Institutions
2,072Shares Held
1.02BCall Options Held
9.63MPut Options Held
10.2M-
Black Rock Inc. New York, NY121MShares$12.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.46 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.28 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.03 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...